1-20 of 26
Anil K. Sood
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles

Sara Corvigno, Anna Maria Johnson, Kwong-Kwok Wong, Min Soon Cho, Vahid Afshar-Kharghan, David G. Menter, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (7): 1067–1075.
https://doi.org/10.1158/1535-7163.MCT-22-0087
Published: 05 July 2022
View article titled, Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles
Open the PDF for Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles in another window
Journal Articles

Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models

Katelyn F. Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, Elaine Stur, Robiya Joseph, Emine Bayraktar, Santosh K. Dasari, Nghi Nguyen, Reid T. Powell, Mary Sobieski, Cristina Ivan, Mark Kim, Sujanitha Umamaheswaran, Deanna Glassman, Yunfei Wen, Paola Amero, Clifford Stephan, Robert L. Coleman, Yosef Landesman, Shannon N. Westin, Prahlad T. Ram, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12): 2352–2361.
https://doi.org/10.1158/1535-7163.MCT-21-0370
Published: 03 December 2021
View article titled, Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
Open the PDF for Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models in another window
Includes: Supplementary data
Journal Articles

Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer

Mark Seungwook Kim, Shaolin Ma, Anca Chelariu-Raicu, Carola Leuschner, Hector W. Alila, Sanghoon Lee, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (11): 2396–2406.
https://doi.org/10.1158/1535-7163.MCT-20-0030
Published: 03 November 2020
View article titled, Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer
Open the PDF for Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1–Mediated Cell Death in Uterine Cancer

Yunfei Wen, Ying Wang, Anca Chelariu-Raicu, Elaine Stur, Yuan Liu, Sara Corvigno, Faith Bartsch, Lauren Redfern, Behrouz Zand, Yu Kang, Jinsong Liu, Keith Baggerly, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (9): 1943–1954.
https://doi.org/10.1158/1535-7163.MCT-19-1026
Published: 02 September 2020
View article titled, Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1–Mediated Cell Death in Uterine Cancer
Open the PDF for Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1–Mediated Cell Death in Uterine Cancer in another window
Includes: Supplementary data
Journal Articles

NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors

Takahito M. Miyake, Sunila Pradeep, Emine Bayraktar, Elaine Stur, Katelyn F. Handley, Sherry Y. Wu, Cristian Rodriguez-Aguayo, Ju-Seog Lee, Gabriel Lopez-Berestein, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (8): 1727–1735.
https://doi.org/10.1158/1535-7163.MCT-19-0977
Published: 04 August 2020
View article titled, NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors
Open the PDF for NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors in another window
Includes: Supplementary data
Journal Articles

GnRH-R–Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition

Shaolin Ma, Sunila Pradeep, Alejandro Villar-Prados, Yunfei Wen, Emine Bayraktar, Lingegowda S. Mangala, Mark Seungwook Kim, Sherry Y. Wu, Wei Hu, Cristian Rodriguez-Aguayo, Carola Leuschner, Xiaoyan Liang, Prahlad T. Ram, Katharina Schlacher, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (5): 969–979.
https://doi.org/10.1158/1535-7163.MCT-18-0770
Published: 01 May 2019
View article titled, GnRH-R–Targeted Lytic Peptide Sensitizes <em>BRCA</em> Wild-type Ovarian Cancer to PARP Inhibition
Open the PDF for GnRH-R–Targeted Lytic Peptide Sensitizes <em>BRCA</em> Wild-type Ovarian Cancer to PARP Inhibition in another window
Includes: Supplementary data
Journal Articles

Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4

Alejandro Villar-Prados, Sherry Y. Wu, Karem A. Court, Shaolin Ma, Christopher LaFargue, Mamur A. Chowdhury, Margaret I. Engelhardt, Cristina Ivan, Prahlad T. Ram, Ying Wang, Keith Baggerly, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Shyh-Ming Yang, David J. Maloney, Makoto Yoshioka, Jeffrey W. Strovel, Jason Roszik, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (2): 421–436.
https://doi.org/10.1158/1535-7163.MCT-18-0365
Published: 04 February 2019
View article titled, Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4
Open the PDF for Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4 in another window
Includes: Supplementary data
Journal Articles

PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

Takeshi Hisamatsu, Michael McGuire, Sherry Y. Wu, Rajesha Rupaimoole, Sunila Pradeep, Emine Bayraktar, Kyunghee Noh, Wei Hu, Jean M. Hansen, Yasmin Lyons, Kshipra M. Gharpure, Archana S. Nagaraja, Lingegowda S. Mangala, Takashi Mitamura, Cristian Rodriguez-Aguayo, Young Gyu Eun, Johnathon Rose, Geoffrey Bartholomeusz, Cristina Ivan, Ju-Seog Lee, Koji Matsuo, Michael Frumovitz, Kwong K. Wong, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (1): 162–172.
https://doi.org/10.1158/1535-7163.MCT-17-1050
Published: 02 January 2019
View article titled, <em>PRKRA</em>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer
Open the PDF for <em>PRKRA</em>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for Cancer

Lin Zhang, Dan Peng, Anil K. Sood, Chi V. Dang, Xiaomin Zhong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (9): 1816–1823.
https://doi.org/10.1158/1535-7163.MCT-18-0124
Published: 04 September 2018
View article titled, Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for Cancer
Open the PDF for Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for Cancer in another window
Journal Articles

Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer

Yan Huang, Wei Hu, Jie Huang, Fangrong Shen, Yunjie Sun, Cristina Ivan, Sunila Pradeep, Robert Dood, Monika Haemmerle, Dahai Jiang, Lingegowda S. Mangala, Kyunghee Noh, Jean M. Hansen, Heather J. Dalton, Rebecca A. Previs, Archana S. Nagaraja, Michael McGuire, Nicholas B. Jennings, Russell Broaddus, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (2): 464–473.
https://doi.org/10.1158/1535-7163.MCT-17-0006
Published: 01 February 2018
View article titled, Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer
Open the PDF for Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer in another window
Includes: Supplementary data
Journal Articles

Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)

Michael J. Wagner, Rahul Mitra, Mark J. McArthur, Wallace Baze, Kirstin Barnhart, Sherry Y. Wu, Cristian Rodriguez-Aguayo, Xinna Zhang, Robert L. Coleman, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (6): 1114–1123.
https://doi.org/10.1158/1535-7163.MCT-16-0541
Published: 01 June 2017
View article titled, Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
Open the PDF for Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA) in another window
Includes: Supplementary data
Journal Articles

HSP70 Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer

Karem A. Court, Hiroto Hatakeyama, Sherry Y. Wu, Mangala S. Lingegowda, Cristian Rodríguez-Aguayo, Gabriel López-Berestein, Lee Ju-Seog, Carlos Rinaldi, Eduardo J. Juan, Anil K. Sood, Madeline Torres-Lugo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (5): 966–976.
https://doi.org/10.1158/1535-7163.MCT-16-0519
Published: 02 May 2017
View article titled, <em>HSP70</em> Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer
Open the PDF for <em>HSP70</em> Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer

Yan Huang, Lenard M. Lichtenberger, Morgan Taylor, Justin N. Bottsford-Miller, Monika Haemmerle, Michael J. Wagner, Yasmin Lyons, Sunila Pradeep, Wei Hu, Rebecca A. Previs, Jean M. Hansen, Dexing Fang, Piotr L. Dorniak, Justyna Filant, Elizabeth J. Dial, Fangrong Shen, Hiroto Hatakeyama, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (12): 2894–2904.
https://doi.org/10.1158/1535-7163.MCT-16-0074
Published: 01 December 2016
View article titled, Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer
Open the PDF for Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth

Jie Huang, Wei Hu, Limin Hu, Rebecca A. Previs, Heather J. Dalton, Xiao-Yun Yang, Yunjie Sun, Michael McGuire, Rajesha Rupaimoole, Archana S. Nagaraja, Yu Kang, Tao Liu, Alpa M. Nick, Nicholas B. Jennings, Robert L. Coleman, Robert B. Jaffe, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (6): 1344–1352.
https://doi.org/10.1158/1535-7163.MCT-15-0144
Published: 02 June 2016
View article titled, Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth
Open the PDF for Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma

Hee Dong Han, Young-Jae Cho, Sung Keun Cho, Yeongseon Byeon, Hat Nim Jeon, Hye-Sun Kim, Byoung-Gie Kim, Duk-Soo Bae, Gabriel Lopez-Berestein, Anil K. Sood, Byung Cheol Shin, Yeong-Min Park, Jeong-Won Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (4): 618–627.
https://doi.org/10.1158/1535-7163.MCT-15-0733-T
Published: 05 April 2016
View article titled, Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma
Open the PDF for Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma in another window
Includes: Supplementary data
Journal Articles

Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer

Rebecca A. Previs, Guillermo N. Armaiz-Pena, Yvonne G. Lin, Ashley N. Davis, Sunila Pradeep, Heather J. Dalton, Jean M. Hansen, William M. Merritt, Alpa M. Nick, Robert R. Langley, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12): 2677–2686.
https://doi.org/10.1158/1535-7163.MCT-14-0630
Published: 06 December 2015
View article titled, Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer
Open the PDF for Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract LB-C09: Hematological and Neurological Expressed 1-Like (HN1L) is a Novel Therapeutic Target for Triple Negative Breast Cancer

Dong Soon Choi, Liu Yi, Cristian Rodriguez-Aguayo, Bhuvanesh Dave, Stephen T.C. Wong, Anil K. Sood, Jenny C. Chang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): LB-C09.
https://doi.org/10.1158/1535-7163.TARG-15-LB-C09
Published: 01 December 2015
View article titled, Abstract LB-C09: Hematological and Neurological Expressed 1-Like (HN1L) is a Novel Therapeutic Target for Triple Negative Breast Cancer
Journal Articles

Targeting c-MYC in Platinum-Resistant Ovarian Cancer

Jeyshka M. Reyes-González, Guillermo N. Armaiz-Peña, Lingegowda S. Mangala, Fatma Valiyeva, Cristina Ivan, Sunila Pradeep, Ileabett M. Echevarría-Vargas, Adrian Rivera-Reyes, Anil K. Sood, Pablo E. Vivas-Mejía
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (10): 2260–2269.
https://doi.org/10.1158/1535-7163.MCT-14-0801
Published: 05 October 2015
View article titled, Targeting c-MYC in Platinum-Resistant Ovarian Cancer
Open the PDF for Targeting c-MYC in Platinum-Resistant Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer

Duangmani Thanapprapasr, Rebecca A. Previs, Wei Hu, Cristina Ivan, Guillermo N. Armaiz-Pena, Piotr L. Dorniak, Jean M. Hansen, Rajesha Rupaimoole, Jie Huang, Heather J. Dalton, Rouba Ali-Fehmi, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (6): 1466–1475.
https://doi.org/10.1158/1535-7163.MCT-14-1077
Published: 04 June 2015
View article titled, <em>PTEN</em> Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer
Open the PDF for <em>PTEN</em> Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer in another window
Includes: Supplementary data
Journal Articles

Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs

Chad V. Pecot, Sherry Y. Wu, Seth Bellister, Justyna Filant, Rajesha Rupaimoole, Takeshi Hisamatsu, Rajat Bhattacharya, Anshumaan Maharaj, Salma Azam, Cristian Rodriguez-Aguayo, Archana S. Nagaraja, Maria Pia Morelli, Kshipra M. Gharpure, Trent A. Waugh, Vianey Gonzalez-Villasana, Behrouz Zand, Heather J. Dalton, Scott Kopetz, Gabriel Lopez-Berestein, Lee M. Ellis, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (12): 2876–2885.
https://doi.org/10.1158/1535-7163.MCT-14-0074
Published: 04 December 2014
View article titled, Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
Open the PDF for Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs in another window
Includes: Supplementary data